Apyx Medical Corporation
APYX
$1.99
-$0.03-1.49%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -6.39% | -7.95% | -3.00% | -4.08% | -10.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.39% | -7.95% | -3.00% | -4.08% | -10.47% |
| Cost of Revenue | -7.86% | -12.34% | -8.29% | 13.38% | 8.53% |
| Gross Profit | -5.47% | -4.77% | 0.39% | -12.84% | -19.25% |
| SG&A Expenses | -23.96% | -29.15% | -18.10% | -15.70% | -1.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.19% | -25.97% | -15.50% | -8.97% | 1.14% |
| Operating Income | 53.60% | 53.88% | 47.23% | 21.61% | -41.25% |
| Income Before Tax | 43.56% | 45.30% | 52.08% | 6.59% | -585.83% |
| Income Tax Expenses | -2.00% | -7.55% | 2.30% | 118.87% | -24.24% |
| Earnings from Continuing Operations | 43.24% | 45.03% | 51.59% | -1.05% | -546.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -233.33% | 57.14% | 82.35% | -54.35% | 20.00% |
| Net Income | 42.37% | 45.22% | 51.83% | -1.60% | -559.56% |
| EBIT | 53.60% | 53.88% | 47.23% | 21.61% | -41.25% |
| EBITDA | 54.70% | 54.89% | 48.33% | 21.57% | -42.77% |
| EPS Basic | 50.95% | 53.41% | 56.33% | -1.65% | -559.23% |
| Normalized Basic EPS | 50.77% | 53.76% | 36.24% | 5.97% | -79.72% |
| EPS Diluted | 50.95% | 53.41% | 56.33% | -1.65% | -559.23% |
| Normalized Diluted EPS | 50.77% | 53.76% | 36.24% | 5.97% | -79.72% |
| Average Basic Shares Outstanding | 17.56% | 17.56% | 10.31% | 0.01% | 0.12% |
| Average Diluted Shares Outstanding | 17.56% | 17.56% | 10.31% | 0.01% | 0.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |